tiprankstipranks
Biogen (BIIB)
NASDAQ:BIIB
Holding BIIB?
Track your performance easily

Biogen (BIIB) Income Statement

4,583 Followers

Biogen Income Statement

Last quarter (Q3 2024), Biogen's total revenue was $2.47B, a decrease of -2.55% from the same quarter last year. In Q3, Biogen's net income was $388.50M. See Biogen’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 9.61B$ 9.84B$ 10.17B$ 10.98B$ 13.44B$ 14.38B
Cost of Revenue
$ 2.35B$ 2.53B$ 2.28B$ 2.11B$ 1.81B$ 1.96B
Gross Profit
$ 7.26B$ 7.30B$ 7.90B$ 8.87B$ 11.64B$ 12.42B
Operating Expense
$ 4.82B$ 5.47B$ 4.99B$ 5.19B$ -7.19B$ -5.39B
Operating Income
$ 3.25B$ 2.75B$ 3.62B$ 4.57B$ 4.45B$ 7.04B
Net Non Operating Interest Income Expense
$ -248.10M$ -29.60M$ 157.30M$ -278.90M$ -180.50M$ -67.40M
Other Income Expense
$ 171.40M$ -563.90M$ 847.20M$ 1.04B$ -781.70M$ -157.60M
Pretax Income
$ 1.91B$ 1.30B$ 3.59B$ 1.75B$ 5.05B$ 7.13B
Tax Provision
$ 291.70M$ 135.30M$ 632.80M$ 52.50M$ 992.30M$ 1.16B
Earnings From Equity Interest Net Of Tax
--$ 1.51B$ 34.90M--
Net Income Common Stockholders
$ 1.62B$ 1.16B$ 3.05B$ 1.56B$ 4.00B$ 5.89B
Basic EPS
$ 11.10$ 8.02$ 20.96$ 10.44$ 24.86$ 31.47
Diluted EPS
$ 11.06$ 7.97$ 20.87$ 10.40$ 24.80$ 31.42
Basic Average Shares
$ 581.40M$ 144.70M$ 145.30M$ 149.10M$ 160.90M$ 187.10M
Diluted Average Shares
$ 584.80M$ 145.60M$ 146.00M$ 149.60M$ 161.30M$ 187.40M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 6.70B$ 8.00B$ 7.27B$ 7.30B$ 8.38B$ 6.61B
Net Income From Continuing And Discontinued Operation
$ 1.62B$ 1.16B$ 3.05B$ 1.56B$ 4.00B$ 5.89B
Normalized Income
$ 2.00B$ 1.24B--$ 3.99B$ 5.57B
Interest Expense
------
EBIT
$ 2.31B$ 1.54B$ 3.84B$ 2.00B$ 5.27B$ 7.07B
EBITDA
$ 3.13B$ 2.04B$ 4.36B$ 2.88B$ 5.73B$ 7.53B
Currency in USD

Biogen Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis